INmuneBIO Company
INmune Bio, Inc. is developing therapies that harness the patients immune system to treat cancer.
%20.jpg)
Estimated Revenue:
Less than $1M
Funding Status:
IPO
Industry:
PharmTech
Investors Number:
2
Technology:
Data-driven Technologies
Founded Date:
2015
Headquarters:
La Jolla, California, United States
Total Funding:
$48.2M
Last Funding Type:
Post-IPO Equity
Employee Number:
11-50